Abiopharma

News list

Farag Kameel D. 🟢 acquired 6.3K shares of Akari Therapeutics Plc (AKTX) at $0.74 Transaction Date: Oct 22, 2025 | Filing ID: 019194

Full text

News bot Oct. 24, 2025, 1:20 p.m.
🔍 Farag Kameel D. (Executive)

Company: Akari Therapeutics Plc (AKTX)

Report Date: 2025-10-22
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 6,277
Detailed Transactions and Holdings:
- Acquired 6,277 shares of American Depositary Shares representing Ordinary Shares at $0.74 per share (Direct)
  Date: 2025-10-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,277.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer
- F2: These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on October 31, 2025.